CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were...
CNBC reports (video) an unusually high volume of call options in Pharmasset (VRUS +84.7%) were purchased just a few days before the buyout of the company by Gilead Sciences (GILD -9.7%). Analysts say the activity may get more than a passing glance look from regulators.
From other sites
at 4-traders.com (Mar 24, 2015)
at MarketRealist.com (Mar 24, 2015)
at Nasdaq.com (Mar 17, 2015)
at Zacks.com (Mar 6, 2015)
at Benzinga.com (Feb 27, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs